Lakewood Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Lakewood Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.81M	Sell	29,851 -9,309	-24%	-$543K	1.16%	26
2025 Q4	$2.11M	Buy	39,160 +1,129	+3%	+$54.3K	1.24%	28
2025 Q3	$1.72M	Buy	38,031 +837	+2%	+$39.1K	1.04%	34
2025 Q2	$1.72M	Buy	37,194 +164	+0.4%	+$8.05K	1.15%	29
2025 Q1	$2.26M	Buy	37,030 +10,163	+38%	+$592K	1.52%	21
2024 Q4	$1.52M	Buy	26,867 +195	+0.7%	+$10.9K	1.05%	28
2024 Q3	$1.38M	Sell	26,672 -2,286	-8%	-$107K	0.94%	32
2024 Q2	$1.2M	Sell	28,958 -135	-0.5%	-$6.04K	0.84%	33
2024 Q1	$1.58M	Buy	29,093 +2,744	+10%	+$140K	1.07%	31
2023 Q4	$1.35M	Sell	26,349 -5,765	-18%	-$303K	1.05%	29
2023 Q3	$1.86M	Sell	32,114 -546	-2%	-$33.5K	1.52%	19
2023 Q2	$2.09M	Buy	32,660 +499	+2%	+$33.5K	1.64%	14
2023 Q1	$2.23M	Buy	32,161 +365	+1%	+$25.7K	1.85%	14
2022 Q4	$2.29M	Buy	+31,796	New	+$2.4M	1.85%	10

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lakewood Asset Management's BMY Position: Q1 2026 in Review

Lakewood Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 24% in Q1 2026, selling an estimated $543K and leaving 29,851 shares worth $1.81M. The position accounts for 1.16% of the portfolio, ranked #26.

Lakewood Asset Management first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.29M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Lakewood Asset Management held 29,851 shares of Bristol-Myers Squibb worth $1.81M as of Q1 2026.
Lakewood Asset Management sold 9,309 Bristol-Myers Squibb shares in Q1 2026, an estimated $543K.
Bristol-Myers Squibb made up 1.16% of Lakewood Asset Management's portfolio in Q1 2026, its #26 holding.
Lakewood Asset Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
Lakewood Asset Management's Bristol-Myers Squibb position peaked at $2.29M in Q4 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Lakewood Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.